Effect of Umbelliferone on pharmacokinetic and pharmacodynamic parameters of Glibenclamide in Streptozocin induced diabetic rats
Article Sidebar
Main Article Content
Abstract
The present investigation aims to determine the effect of Umbelliferone (UMB) on pharmacokinetic (PK) and pharmacodynamic (PD) parameters of Glibenclamide (GLB) in diabetic rats. Simultaneously, the effect was studied in normal rats. Diabetes in rats was induced by Streptazocin (STZ). The PK parameters are calculated in normal and diabetic rats. PD studies were performed only on diabetic rats. From the PK results, about 2.0-fold improvement in the oral bioavailability of GLB in diabetic rats was observed when treated with GLB in normal rats. A single-dose (SD) and multi-dose (MD) administration of GLB + UMB showed about 3.8 and 4.0-fold enhancement in oral bioavailability of GLB, respectively in the diabetic group compared with the normal GLB-treated group. Similarly, SD and MD of GLB + UMB showed 2.8-folds and 2.7-folds, respectively in diabetic rats when compared with SD and MD of GLB + UMB in normal rats. Further, the rate of clearance and also the volume of distribution significantly changed in diabetic rats. No significant differences were observed in the PK parameters of SD and MD of GLB+ UMB treated groups in diabetic rats. The blood glucose levels were significantly (p<0.05) reduced (12.0 and 13.5% after SD and MD of GLB + UMB treatment, respectively) compared to GLB alone treated diabetic rats during a period of 24 h were noticed from PD studies. The maximum reduction was observed at 2 h (44.3 and 45.6 % after SD and MD of GLB + UMB treatment, respectively) compared with standard GLB treatment (32.1%).
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Prihanti, G. S., Badzlina, Tsani, M. A., Zaharah, N., Khasanah, I. N., & Lestari, N. D. (2024). Effect of Ginger (Zingiber officinale), Cinnamon (Cinnamomum verum), Cloves (Syzygium aromaticum), and their Combination on Blood Glucose, Superoxide Dismutase, and Malondialdehyde Levels in Diabetic Rat. Trop J Nat Prod Res, 8(5), 7093–7096.
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe K, Ostolaza H, Martin C. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020; 21(17):1-34.
Pradeepa R, Mohan V, Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021; 69(11): 2932-2938.
Yaribeygi H, Sathyapalan T, Sahebkar A. Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity. Life Sci. 2019; 234(1): 1-7.
Yau M, Maclaren NK, Sperling MA. Etiology and Pathogenesis of Diabetes Mellitus in Children and Adolescents 2000 [Updated 2021 Jun 19] Available from: https://www.ncbi.nlm.nih.gov/books/NBK498653/
Dey L, Attele AS, Yuan CS. Alternative therapies for type 2 diabetes. 2002; Altern Med Rev.7(1): 45-58.
Ling Z, Wang Q, Stange G, In't Veld P, Pipeleers D. Glibenclamide treatment recruits beta-cell subpopulation into elevated and sustained basal insulin synthetic activity. Diabetes.2006; 55(1): 78-85.
Chaughule RS and Barve RS. Role of herbal medicines in the treatment of infectious diseases. Vegetos. 2024; 37(1): 41-51.
Modak M, Dixit P, Londhe J, Ghaskadbi S and Devasagayam TP. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr. 2007; 40(3): 163-173.
Kornicka A, Balewski Ł, Lahutta M, Kokoszka J. Umbelliferone and Its Synthetic Derivatives as Suitable Molecules for the Development of Agents with Biological Activities: A Review of Their Pharmacological and Therapeutic Potential. J. Pharm 2023;16(12):1-61.
Chandramohan R. and Pari L. Protective effect of umbelliferone on high-fructose diet-induced insulin resistance and oxidative stress in rats. Biomed. Aging Pathol. 2014; 4(1): 23-28.
Orororo, O. C.; Mordi, J. C.; Opute, U. A.; Efejene, I. O.; Egbune, E. O.; Busari, A. A. Black Seed Oil-Induced Amelioration of Renal Dysfunction in a Rat Model of Diabetes Mellitus and Periodontitis. Trop J Nat Prod Res 2023;7(7): 3524-3531.
Seena T. Pandarekandy P, Sreejesh G, Harikumaran B, Thampi S and Sreekumaran E. Hypoglycaemic Effect of Glibenclamide: A Critical Study on the Basis of Creatinine and Lipid Peroxidation Status of Streptozotocin-induced Diabetic Rat. Indian J Pharm Sci. 2017;79(5):768-777
Yuqing Li, Yuhui Wei, Fan Zhang, Dan Wang, Xinan Wu. Changes in the pharmacokinetics of glibenclamide in rats with streptozotocin-induced diabetes mellitus. Acta Pharm. Sin. B. 2012; 2(2):198-204.
Jyothi P, Thirupathi G and Narasimha Reddy Y. influence of diosgenin on pharmacokinetics and pharmacodynamics of repaglinide in rats. Int J Pharm Biol Sci. 2017; 7(1) :2230-7605
Ahmad A, Khan RM, Alkharfy KM, Raish M, Al-Jenoobi FI, Al-Mohizea AM. Effects of Thymoquinone on the Pharmacokinetics and Pharmacodynamics of Glibenclamide in a Rat Model. Nat Prod Commun. 2015;10(8):1395-1398.
Parasuraman S, Zhen K and Raveendran R. Retro-orbital Blood Sample Collection in Rats-a Video Article. PTB Reports. 2015; 1: 37-40.
Ahmad A, Khan RMA, Alkhar KM. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Glibenclamide and Thymoquinone in Rat Plasma and Its Application to Pharmacokinetics. Acta Chromatogr. 2015;27(3): 435–448.
Nagaraj B, Veeresham C. Effect of ashwagandha on pharmacokinetic and pharmacodynamic parameters of glimepiride in streptozotocin-induced diabetic rats. Asian J Pharm Clin Res. 2018;11(4):207-210.
Samala S, Sandhya R, Tatipamula C and Veeresham C. Determination of Glimepiride in Rat Serum by Rp-Hplc Method. AJAC. 2011; 2: 152-157.
Yuqing Li, Yuhui Wei, Fan Zhang, Dan Wan, Xinan Wu. Changes in the pharmacokinetics of glibenclamide in rats with streptozotocin-induced diabetes mellitus. Acta Pharm. Sin. B. 2012; 2(2): 198-204.